Community Connection: Ovarian Cancer Canada is looking for volunteers! Could you help?
OVdialogue – consider joining our team in the role of Community Champion. Over a few hours each week, you would be part of a team that helps connect people, support conversations and are thought leaders for OVdialogue. This is your opportunity to give back to those who have/continue to support you through the tough times, share your unique experiences, and help celebrate successes. For more details of what this entails, please reach out to @Mfallis (mfallis@ovariancanada.org).
OVdialogue – consider joining our team in the role of Community Champion. Over a few hours each week, you would be part of a team that helps connect people, support conversations and are thought leaders for OVdialogue. This is your opportunity to give back to those who have/continue to support you through the tough times, share your unique experiences, and help celebrate successes. For more details of what this entails, please reach out to @Mfallis (mfallis@ovariancanada.org).
Pembrolizumab combination with Bevacizumab and oral Cyclophosphamide
Comments
-
Hi @DeltaRed I'm wondering where you referenced this protocol. Is it a current clinical trial here in Canada? These drugs are associated with immunotherapy which is a developing focus for treatment of OVC but not sure where you might have read of the effectiveness of the combination. Could you provide a bit more context for your question?0
-
My question was if anyone has tried this?
my research was personally looking around on internet.Also, read a JAMA Oncology investigation0
